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CASE
A 27-year-old woman was admitted on 14 May
2007, into the hospital of Famagusta (Cyprus) with
an 11-day fever (up to 39.5C). She reported no
direct contact with domestic animals or ticks;
however, she lived in a rural area, where sheep
and goats are abundant. On physical examination,
hepatosplenomegaly and an enlarged lymph node
were observed. Initial laboratory examination
demonstrated moderate anaemia (Hb 11.5 g ⁄dL),
thrombocytopenia (PLT 95000), increased trans-
aminases (AST 178 u ⁄L, ALT 313 u ⁄L), cGT
(79 u ⁄L), LDH (698 u ⁄L) and increased CRP
(10.4 mg ⁄L) and ESR (80 mm ⁄h). The electrocar-
diogram and the chest axial tomography were
negative, as were blood cultures, antibody tests
against CMV, EBV, hepatitis, HIV, mycoplasma,
coxackievirus, adenovirus and parvovirus and
tests for rheumatoid disease. The patient was
treated with doxycycline (200 mg ⁄day for
11 days), ceftriaxone (2 g ⁄day for 5 days) and
imipenem-cilastatin (1500 mg ⁄day for 1 day),
recovered and was discharged 17 days after hos-
pitalisation.
Blood samples were taken from the patient on
admission into the hospital, and 7 days and
3 months later.
LABORATORY TESTS
The patient’s sera were tested for the presence of
IgG and IgM antibodies against A. phagocytophi-
lum antigen using the indirect immunoﬂuorescent
assay (IFA) with a commercial kit (VMRD
Inc.,Veterinary Medical Research & Development,
Pullman, USA). IgG titres of ‡1 ⁄ 100 and IgM titres
of ‡1 ⁄ 40 were considered positive.
An epidemiological investigation was con-
ducted in the area where the patient lived; 40
whole blood samples were drawn (10 from goats
and 30 from sheep). All animal samples, along
with the patient’s three whole blood samples,
were transferred to the Laboratory of Clinical
Bacteriology, Parasitology, Zoonoses and Geo-
graphical Medicine (Crete, Greece). With regard
to animal blood samples, four pools were made
based on animal species. DNA was extracted
from the patient’s three blood samples as well as
from the animal’s pooled blood samples, using
the QIAamp DNA blood mini kit (Qiagen GmbH,
Hilden, Germany), according to the manufac-
turer’s instructions.
PCR reactions were carried out using primers
EHR16SD and EHR16SR targeting the Anaplas-
matic 16s rRNA gene [1]. Positive PCR products
were puriﬁed (QIAquick PCR puriﬁcation spin
kit – Qiagen Hilden, Germany) and directly
sequenced (sequencer CEQ 8000 Beckman Coulter
– Bioanalytica, Genotype, Athens, Greece).
RESULTS
Serology analysis showed: IgG antibody titres of
0, 0, 1 ⁄ 128 and IgM antibody titres of 1 ⁄ 20, 1 ⁄ 20,
1 ⁄ 20 against Anaplasma phagocytophilum, respec-
tively, for the patient’s three sera samples.
The ﬁrst of the patient’s three blood samples
was positive by PCR; the other two were negative.
All four animal blood pools were positive by PCR.
Sequence alignment of the ﬁve amplicons
obtained from both the patient (EU448141, named
Anaplasma sp. panagCy) and the animals
(EU090185) demonstrated 100% homology with
each other and 100% homology with Anaplasma
sp. (EU090185).
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DISCUSSION
The ﬁrst description of anaplasmosis in humans
was communicated in the USA in 1994, while the
ﬁrst conﬁrmed case in Europe was described in
Slovenia in 1997 [2]. I. ricinus is the recognised
vector in Europe [3]. Anaplasmosis is a clinical
syndrome most commonly manifested by non-
speciﬁc fever, chills, headache and myalgia.
Leukopenia, a left shift, thrombocytopenia, and
hepatic transaminase elevations are present in the
majority of the patients. Infection can be severe,
with nearly half of the patients requiring hospi-
talisation [4]. The diagnosis can be conﬁrmed by
PCR, especially during early infection when
antibodies are not detectable yet. The recom-
mended therapy for adults is doxycycline 100 mg
given orally at 12-h intervals [4].
A. phagocytophilum has been found to persist in
various species, sheep and cattle being among
them. Several 16S rRNA A. phagocytophilum vari-
ants have been found in mammals, and there is
ﬁeld evidence that sheep are natural hosts of the
pathogen [5]. The presence of different variants of
the pathogen even in the same ﬂock may cause
differences both in clinical and immunosuppres-
sive reactions if humans get infected by such
variants of the pathogen.
Past reports [2] have described an absolute
similarity among Anaplasma sequences derived
from I. ricinus ticks and those of Slovenian
patients infected by the bacterium. With regard
to Cyprus, this is the ﬁrst report attempting to
describe a 100% similarity among Anaplasma
sequences detected in goats, sheep and a patient,
all derived from the same location, although it
should be highlighted that the alignments con-
sisted of only 300 bp, making the ﬁnal conclusion
indeﬁnite.
Past reports have revealed the presence of
Anaplasma sp., in Cyprus, in a child, in animals
of veterinary importance and in tick species
(Hyalomma sulcata, Rhipicephalus turanicus, Rhipi-
cephalus sanguineus and Ixodes ventalloi) other than
I. ricinus. Further studies are needed to categorise
these species as vectors of the pathogen.
Nevertheless, clinicians in Cyprus should bear
in mind the possibility of infection by Anaplasma
in patients with an epidemiological history of
residence in rural areas and ⁄ or increased possi-
bility of contact with carriers of the pathogen.
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